Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mascha Binder

Showing results (41-50 of 168) with videos related to

Pageof 17
Sort By:
Plos One|July 9, 2020
Impact of bone marrow involvement on outcome in relapsed and refractory transplant eligible diffuse large B-cell lymphoma and transformed indolent lymphomaDenis Terziev, Marcus Bauer, Lisa Paschold, et al.
Blood|January 5, 2013
CLL B-cell receptors can recognize themselves: alternative epitopes and structural clues for autostimulatory mechanisms in CLLMascha Binder, Fabian Müller, Mareike Frick, et al.
The Journal of Clinical Investigation|October 16, 2020
SARS-CoV-2-specific antibody rearrangements in prepandemic immune repertoires of risk cohorts and patients with COVID-19Lisa Paschold, Donjete Simnica, Edith Willscher, et al.
Leukemia & Lymphoma|June 3, 2014
Multiparameter flow cytometry in the differential diagnosis of aberrant T-cell clones of unclear significanceAnna Flammiger, Ulrike Bacher, Maximilian Christopeit, et al.
Oncotarget|August 21, 2014
Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKLAneta Schieferdecker, Mareike Voigt, Kristoffer Riecken, et al.
Immunology|May 27, 2023
Autoantigen-selected B cells are bystanders in spontaneous T cell-driven experimental autoimmune hepatitisDavid Lübbering, Max Preti, Lena Schlott, et al.
Acta Haematologica|December 5, 2012
Allogeneic hematopoietic stem cell transplantation: an option for long-term survival for patients with simultaneous appearance of myeloid and lymphatic malignanciesThomas Weber, Sunday Ocheni, Mascha Binder, et al.
Oncology Research and Treatment|July 21, 2021
Outcome of a Real-World Patient Cohort with Secondary CNS Lymphoma Treated with High-Intensity Chemoimmunotherapy and Autologous Stem Cell TransplantationBenjamin Thiele, Mascha Binder, Simon Schliffke, et al.
Blood|February 25, 2018
The phosphotyrosine phosphatase SHP2 promotes anergy in chronic lymphocytic leukemiaSimon Schliffke, Sophia Buhs, Sarah Bolz, et al.
Blood Cancer Journal|January 29, 2022
Azacitidine-induced reconstitution of the bone marrow T cell repertoire is associated with superior survival in AML patientsJuliane Grimm, Donjete Simnica, Nadja Jäkel, et al.
Pageof 17

Showing results (41-50 of 168) with videos related to

Sort By:
Pageof 17
Plos One|July 9, 2020
Impact of bone marrow involvement on outcome in relapsed and refractory transplant eligible diffuse large B-cell lymphoma and transformed indolent lymphomaDenis Terziev, Marcus Bauer, Lisa Paschold, et al.
Blood|January 5, 2013
CLL B-cell receptors can recognize themselves: alternative epitopes and structural clues for autostimulatory mechanisms in CLLMascha Binder, Fabian Müller, Mareike Frick, et al.
The Journal of Clinical Investigation|October 16, 2020
SARS-CoV-2-specific antibody rearrangements in prepandemic immune repertoires of risk cohorts and patients with COVID-19Lisa Paschold, Donjete Simnica, Edith Willscher, et al.
Leukemia & Lymphoma|June 3, 2014
Multiparameter flow cytometry in the differential diagnosis of aberrant T-cell clones of unclear significanceAnna Flammiger, Ulrike Bacher, Maximilian Christopeit, et al.
Oncotarget|August 21, 2014
Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKLAneta Schieferdecker, Mareike Voigt, Kristoffer Riecken, et al.
Immunology|May 27, 2023
Autoantigen-selected B cells are bystanders in spontaneous T cell-driven experimental autoimmune hepatitisDavid Lübbering, Max Preti, Lena Schlott, et al.
Acta Haematologica|December 5, 2012
Allogeneic hematopoietic stem cell transplantation: an option for long-term survival for patients with simultaneous appearance of myeloid and lymphatic malignanciesThomas Weber, Sunday Ocheni, Mascha Binder, et al.
Oncology Research and Treatment|July 21, 2021
Outcome of a Real-World Patient Cohort with Secondary CNS Lymphoma Treated with High-Intensity Chemoimmunotherapy and Autologous Stem Cell TransplantationBenjamin Thiele, Mascha Binder, Simon Schliffke, et al.
Blood|February 25, 2018
The phosphotyrosine phosphatase SHP2 promotes anergy in chronic lymphocytic leukemiaSimon Schliffke, Sophia Buhs, Sarah Bolz, et al.
Blood Cancer Journal|January 29, 2022
Azacitidine-induced reconstitution of the bone marrow T cell repertoire is associated with superior survival in AML patientsJuliane Grimm, Donjete Simnica, Nadja Jäkel, et al.
Pageof 17